Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecentriq
Tecentriq
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Keytruda
Merck
Roche
Tecentriq
Avastin
lung cancer
Roche yanks Tecentriq kidney cancer applications as Merck, Pfizer speed toward approvals
Fierce Pharma
Tue, 11/20/18 - 12:15 pm
Roche
Merck
Pfizer
Tecentriq
kidney cancer
Roche’s Tecentriq gets fast review in triple negative breast cancer
Pharmaforum
Tue, 11/13/18 - 09:51 am
Roche
Genentech
Tecentriq
Celgene
Abraxane
FDA
triple negative breast cancer
Benefit of Roche's Tecentriq looks limited in breast cancer
Biopharma Dive
Sat, 10/20/18 - 11:01 pm
Roche
Tecentriq
breast cancer
triple negative breast cancer
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Tue, 10/16/18 - 09:42 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Tecentriq sets the bar in small-cell lung cancer
Biopharma Dive
Tue, 09/25/18 - 11:08 pm
Roche
Tecentriq
Small-Cell Lung Cancer
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Genentech
Roch
Tecentriq
Avastin
lung cancer
FDA
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
US agency to rule on Tecentriq’s most important use
EP Vantage
Wed, 08/15/18 - 11:57 am
Roche
Tecentriq
non-squamous non-small cell lung cancer
FDA
FDA Limits the Use of Tecentriq and Keytruda
RAPS.org
Wed, 07/4/18 - 11:25 am
FDA
Roche
Merck
Tecentriq
Keytruda
metastatic urothelial cancer
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Roche
Tecentriq
Genentech
triple negative breast cancer
Celgene
Abraxane
With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?
Fierce Pharma
Mon, 06/25/18 - 12:39 pm
Roche
Tecentriq
clinical trials
small cell lung cancer
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
Biopharma Dive
Fri, 06/22/18 - 12:13 pm
FDA
Merck
Keytruda
Roche
Tecentriq
bladder cancer
ASCO18: Tecentriq scores again in lung cancer, but Keytruda looms in background
Biopharma Dive
Sat, 06/2/18 - 01:39 pm
Roche
Tecentriq
ASCO 2018
chemotherapy
advanced squamous non-small cell lung cancer
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
CP Wire
Fri, 06/1/18 - 09:55 am
Exelixis
clinical trials
Cabometyx
Tecentriq
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
Fri, 06/1/18 - 09:37 am
Exelixis
Cabometyx
Tecentriq
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
clinical trials
Roche
Genentech
Genmab
JNJ
cancer
Tecentriq
Darzalex
Roche’s Tecentriq scores again on a pivotal frontline lung cancer trial, positioning them against Merck, Bristol-Myers
Endpoints
Tue, 05/29/18 - 08:54 am
Roche
Tecentriq
anti-PD-L1
non-squamous non-small cell lung cancer
Merck
Bristol-Myers Squibb
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
Biopharma Dive
Mon, 05/21/18 - 09:44 pm
FDA
clinical trials
oncologists
bladder cancer
Merck
Keytruda
Roche
Tecentriq
Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer
CP Wire
Thu, 05/10/18 - 09:57 am
Roche
Exelixis
Tecentriq
Cotellic
colorectal cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »